At Mundipharma, our dedicated Global Scientific Affairs team continuously explores innovative therapeutic areas that address unmet medical needs. Our commitment to scientific excellence and putting the patient at the heart of all we do, drives us to continue to help improve health outcomes and enhance the quality of life for patients worldwide, when it matters most to them and their families.
Our Therapeutic Areas
Our medicines and therapeutic areas include anti-infectives, oncology, pain management with a focus on cancer and supportive care, biosimilars, respiratory, central nervous system (CNS) and ophthalmology.
Our Medicines
Below is a general overview of the products that we offer. This list is not exhaustive and in order to comply with regulations, we are unable to provide detailed product information on this website. Not all products are available in all markets. Additionally, currently approved indications and presentations may differ between countries. Please always ask a healthcare professional for advice regarding medicines and refer to individual countries for full product indication and local prescribing information.
Download our Charter on the responsible medical use of opioid analgesics in pain management
MST® Continus® (morphine)
Norspan®/BuTrans®/Restiva® (buprenorphine)
Nyxoid® (naloxone)
OxyContin® (oxycodone)
OxyNorm® (oxycodone)
Palladone® (hydromorphone)
Substitol® (morphine)
Targin® (oxycodone/naloxone)
Zytram® (tramadol) [Tramal]
Pelmeg® (pegfilgrastim)
This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.yellowcard.mhra.gov.uk for how to report side effects.
Cosopt/Trusopt® (dorzolamide hydrochloride)
Timoptic® (timolol maleate)
Eligard® (leuprorelin)
Folotyn®/Difolta® (pralatrexate)
Mundesine® (Forodesine)
Zevalin® (ibritumomab tiuxetan)
flutiform® (fluticasone/ formoterol)
Lodotra® (prednisone)
Biphentin® / FoQuest® (methylphenidate)
Anerem® (remimazolam)
REZZAYO® (rezafungin)
Report a side effect
Patient safety is very important to us.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. By reporting side effects, you can help provide more information on the safety of medicine.
In the UK, you can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
Please note that the medicines mentioned may not be available in all countries. Additionally, currently approved indications and presentations may differ between countries. Please always ask a healthcare professional for advice regarding medicines and refer to individual countries for full product indication and local prescribing information.